Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease

REFERENCES

• Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10: 7895–903.
   PubMed Web of Science ®Google Scholar
• Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P. Sequence of the p52 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 1984; 12: 2861–78.
   Google Scholar
• Prud'homme JF, Fridlansky F, Le Cunff M, Atger,M, Mercier-Bodart C, Pichon MF,Milgrom E. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 1985; 4: 11–21.
   Google Scholar
• Jorgensen KH, Thim L, Jacobsen HE. Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new poly-peptide from porcine pancreas. Regul Pept 1982; 3: 207–19.
   Google Scholar
• Thim L, Jorgensen KH, Jorgensen KD. Pancreatic spasmolytic polypeptide (PSP): II. Radioimmuno-logical determination of PSP in porcine tissues, plasma and pancreatic juice. Regul Pept 1982; 3: 221–30.
   Google Scholar
• Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 1991; 88: 11017–21.
   PubMed Web of Science ®Google Scholar
• Hauser F, Poulsom R, Chinery R, Rogers LA, Hanby AM, Wright NA, Hoffmann W. hPl.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 1993; 90: 6961–5.
   Google Scholar
• Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, De Beaumont M, Sands BE, Mahida YR. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993; 268: 6694–702.
   Google Scholar
• Thim L. A new family of growth factor-like peptides. "Trefoil" disulphide loop structures as a common feature in breast cancer associated peptide (p52), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989; 250: 85–90.
   Google Scholar
• Thim L. Trefoil peptides: from structure to function. Cell Mol Life Sci 1997; 53: 888–903.
   PubMed Web of Science ®Google Scholar
• Thim L, Wöldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK. Characteriza-tion of human and rat intestinal trefoil factor produced in yeast. Biochemistry 1995; 34: 4757 — 64.
   PubMed Web of Science ®Google Scholar
• Chadwick MP, Westley BR, May FE. Homo-dimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/p52 through cysteine 58. Biochem J 1997; 327: 117–23.
   Google Scholar
• Newton JL, Allen A, Westley BR, May FEB. The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut 2000; 46: 312–20.
   PubMed Web of Science ®Google Scholar
• Kannan R, Tomasetto C, Staub A, Bossenmeyer-Pourie C, Thim L, Nielsen PF, Rio MC. Human pS2/trefoil factor 1: production and characterization in Pichia pastoris. Protein Expr Purif 2001; 21: 92— 8.
   Google Scholar
• Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, Batzenschlager A, Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988; 241(4866): 705–8.
   PubMed Web of Science ®Google Scholar
• Rio MC, Chenard MP, Wolf C, Marcellin L, Tomasetto C, Lathe R, Bellocq JP, Chambon P. Induction of p52 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastro-enterology 1991; 100: 375–9.
   PubMed Web of Science ®Google Scholar
• Wright NA, Poulsom R, Stamp G, Van Noorden S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C, Rio MC, Chambon P. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993; 104: 12–20.
   Google Scholar
• Babyatsky MW, de Beaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol-induced and indomethacin-induced gastric injury in rats. Gastroenterology 1996; 110: 489–97.
   PubMed Web of Science ®Google Scholar
• Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274(5285): 262–5.
   PubMed Web of Science ®Google Scholar
• Poulsen SS, Thulesen J, Christensen L, Nexo E, Thim L. Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 1999; 45: 516–22.
   Google Scholar
• Marchbank T, Cox HM, Goodlad RA, Giraud AS, Moss SF, Poulsom R, Wright NA, Jankowski J, Playford RJ. Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice. J Biol Chem 2001; 276: 24088–96.
   Google Scholar
• Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990; 343(6253): 82–5.
   Google Scholar
• Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, Wright NA. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000; 47: 792— 800.
   Google Scholar
• May FE, Westley BR. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J Pathol 1997; 182: 404–13.
   PubMed Web of Science ®Google Scholar
• Vestergaard EM, Poulsen SS, Gronbxk H, Larsen R, Nielsen AM, Ejskjxr K, Clausen JT, Thim L, Nexo E. Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem 2002; 48: 1689–95.
   Google Scholar
• Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3–11.
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962— 87: a sixfold increase in incidence. Scand J Gastro-enterol 1992; 27: 609–14.
   Google Scholar
• Thim L, Norris K, Norris F, Nielsen PF, Bjorn SE, Christensen M, Petersen J. Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett 1993; 318: 345–52.
   Google Scholar
• Kohler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976; 6: 511–9.
   PubMed Web of Science ®Google Scholar
• Taggart RT, Samloff IM. Stable antibody-producing murine hybridomas. Science 1983; 219(4589): 1228–30.
   PubMed Web of Science ®Google Scholar
• Fraser CG, Harris EK. Generation and applica-tion of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409–37.
   PubMed Web of Science ®Google Scholar
• Solberg H. Establishment and use of reference values. In: Tietz N, editor. Textbook of clinical chemistry. Philadelphia: WB Saunders; 1986. p. 356–86.
   Google Scholar
• Semple JI, Newton JL, Westley BR, May FEB. Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice. Gut 2001; 48: 648–55.
   PubMed Web of Science ®Google Scholar
• Duclos B, Rio MC, Reimund JM, Chamouard P, Baumann R, Chambon P, Weill JP. Increased p52 secretion in serum of Crohn's disease (CD) patients. Gastroenterology 1991; 100 Suppl: A520 (Abstract).
   Google Scholar
• Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulcera-tion leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995; 175: 405–14.
   PubMed Web of Science ®Google Scholar
• Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 2002; 32: 519–27.
   Google Scholar